Lisata Therapeutics Inc

The current institutional shareholding score of Lisata Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 10.92%, representing a quarter-over-quarter increase of 34.03%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.46% of shares outstanding, with 0.94% increase in holdings.